UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. ______)*
 
PROTOKINETIX, INC.
(Name of Issuer)
 
Common Stock, $ .0000053 par value
(Title of Class of Securities)
 
743722100
(CUSIP Number)
 
Dr. John D. Todd
15545 Cliff Avenue
White Rock, B.C., Canada, V4B 1V8
604-535-0156
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
 
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ]

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 
 

CUSIP No. 743722100


 
1.
 
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only).
 
 
Dr. John D. Todd
 
2.
 
Check the Appropriate Box if a Member of a Group
 
(a)
(b)
 
3.
 
SEC Use Only
 
4.
 
Source of Funds
 
OO
 
5.
 
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
  
 
6.
 
Citizenship or Place of Organization
 
Canada
Number of Shares Beneficially Owned by Each Reporting  Person  With
 
7.
 
Sole Voting Power
 
3,130,000
 
8.
 
Shared Voting Power
  
 
9.
 
Sole Dispositive Power
 
3,130,000
 
10.
 
Shared Dispositive Power
  
 
11.
 
Aggregate Amount Beneficially Owned by Each Reporting Person
 
3,130,000
 
12.
 
Check if the Aggregate Amount in Row (11) Excludes Certain Shares
  
 
13.
 
Percent of Class Represented by Amount in Row (11)
 
7.01%
 
14.
 
Type of Reporting Person (See Instructions)
 
IN

 
Item 1. Security and Issuer
 
Title of Class of Equity Securities: Common Stock, $.0000053 par value

Address of Issuer:  Suite 1500-855 West Georgia Street, Vancouver, British Columbia, Canada V6C3E.

Item 2. Identity and Background
 
(a)  Dr. John D. Todd, 

(b) 15545 Cliff Avenue, White Rock, B.C., Canada, V4B 1V8

(c) Chief Executive Officer, Protokinetix Inc., Suite 1500-855 West Georgia Street, Vancouver, British Columbia, Canada V6C3E.

(d) Reporting person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years.

(e) Reporting person has not been a party to a civil proceeding of a judicial or administrative body resulting in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violation with respect to such laws.

(f) Canada

Item 3. Source and Amount of Funds or Other Consideration
 
Payment for services rendered as chief executive officer of Protokinetix, Inc.
 
Item 4. Purpose of Transaction

See Item 3 above.

(a) Not Applicable.

(b)  Not Applicable.

(c)  Not Applicable.

(d) Not Applicable.

(e)  Not Applicable.

(f)  Not Applicable.

(g)  Not Applicable.

(h) Not Applicable.

(i) Not Applicable.

(j) Not Applicable.

Item 5. Interest in Securities of the Issuer
 
(a) The aggregate number of shares of common stock to which this Schedule 13D relates is 3,130,000 shares, representing 7.01% of the 44,590,639 shares of ProtoKinetix, Inc.’s common stock outstanding as of April 3, 2007.
 
(b) John Todd has sole voting and dispositive power over 2,730,000 shares of ProtoKinetix, Inc.’s common stock which he owns solely in his name as well as an additional 400,000 shares held in the name of J.D. Todd Medical Inc. Dr. Todd is the sole signing authority for J.D. Todd Medical Inc.
 
(c) See Item 3, above.
 
(d) Not Applicable.
 
(e) Not Applicable.
 
Item 6.
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
 
See Item 3, above.
 
Item 7. Material to Be Filed as Exhibits
 
Not Applicable
 

 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Dated: April 3, 2007      
 
/s/ Dr. John D. Todd
_______________________________
By: Dr. John D. Todd

.